- Home
- PCVX vs DOCU Comparison
PCVX vs DOCU Comparison
Compare PCVX & DOCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- DOCU
- Stock Information
- Founded
- PCVX 2013
- DOCU 2003
- Country
- PCVX United States
- DOCU United States
- Employees
- PCVX N/A
- DOCU N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- DOCU EDP Services
- Sector
- PCVX Health Care
- DOCU Technology
- Exchange
- PCVX Nasdaq
- DOCU Nasdaq
- Market Cap
- PCVX 13.2B
- DOCU 14.4B
- IPO Year
- PCVX 2020
- DOCU 2018
- Fundamental
- Price
- PCVX $86.51
- DOCU $79.11
- Analyst Decision
- PCVX Strong Buy
- DOCU Hold
- Analyst Count
- PCVX 7
- DOCU 15
- Target Price
- PCVX $147.50
- DOCU $63.00
- AVG Volume (30 Days)
- PCVX 1.4M
- DOCU 2.4M
- Earning Date
- PCVX 11-05-2024
- DOCU 12-05-2024
- Dividend Yield
- PCVX N/A
- DOCU N/A
- EPS Growth
- PCVX N/A
- DOCU N/A
- EPS
- PCVX N/A
- DOCU 4.72
- Revenue
- PCVX N/A
- DOCU $2,858,474,000.00
- Revenue This Year
- PCVX N/A
- DOCU $8.84
- Revenue Next Year
- PCVX N/A
- DOCU $5.89
- P/E Ratio
- PCVX N/A
- DOCU $16.77
- Revenue Growth
- PCVX N/A
- DOCU 7.70
- 52 Week Low
- PCVX $48.24
- DOCU $42.12
- 52 Week High
- PCVX $121.06
- DOCU $83.68
- Technical
- Relative Strength Index (RSI)
- PCVX 23.31
- DOCU 67.25
- Support Level
- PCVX $101.87
- DOCU $69.28
- Resistance Level
- PCVX $107.31
- DOCU $83.68
- Average True Range (ATR)
- PCVX 5.82
- DOCU 2.14
- MACD
- PCVX -2.04
- DOCU 0.48
- Stochastic Oscillator
- PCVX 3.58
- DOCU 69.74
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About DOCU DocuSign Inc.
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in May 2018.